rs5992493

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000491939.6(TXNRD2):​c.*1100T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.267 in 152,196 control chromosomes in the GnomAD database, including 7,699 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.27 ( 7699 hom., cov: 33)
Exomes 𝑓: 0.25 ( 0 hom. )

Consequence

TXNRD2
ENST00000491939.6 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.314
Variant links:
Genes affected
TXNRD2 (HGNC:18155): (thioredoxin reductase 2) The protein encoded by this gene belongs to the pyridine nucleotide-disulfide oxidoreductase family, and is a member of the thioredoxin (Trx) system. Three thioredoxin reductase (TrxR) isozymes are found in mammals. TrxRs are selenocysteine-containing flavoenzymes, which reduce thioredoxins, as well as other substrates, and play a key role in redox homoeostasis. This gene encodes a mitochondrial form important for scavenging reactive oxygen species in mitochondria. It functions as a homodimer containing FAD, and selenocysteine (Sec) at the active site. Sec is encoded by UGA codon that normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, the Sec insertion sequence (SECIS) element, which is necessary for the recognition of UGA as a Sec codon rather than as a stop signal. Alternatively spliced transcript variants encoding different isoforms, including a few localized in the cytosol and some lacking the C-terminal Sec residue, have been found for this gene. [provided by RefSeq, Jun 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.529 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TXNRD2NM_006440.5 linkuse as main transcriptc.949+1374T>C intron_variant ENST00000400521.7 NP_006431.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TXNRD2ENST00000400521.7 linkuse as main transcriptc.949+1374T>C intron_variant 1 NM_006440.5 ENSP00000383365 P4Q9NNW7-1

Frequencies

GnomAD3 genomes
AF:
0.267
AC:
40559
AN:
152062
Hom.:
7664
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.534
Gnomad AMI
AF:
0.0746
Gnomad AMR
AF:
0.200
Gnomad ASJ
AF:
0.177
Gnomad EAS
AF:
0.0558
Gnomad SAS
AF:
0.206
Gnomad FIN
AF:
0.125
Gnomad MID
AF:
0.149
Gnomad NFE
AF:
0.170
Gnomad OTH
AF:
0.243
GnomAD4 exome
AF:
0.250
AC:
4
AN:
16
Hom.:
0
Cov.:
0
AF XY:
0.200
AC XY:
2
AN XY:
10
show subpopulations
Gnomad4 FIN exome
AF:
0.167
Gnomad4 NFE exome
AF:
0.333
Gnomad4 OTH exome
AF:
0.250
GnomAD4 genome
AF:
0.267
AC:
40666
AN:
152180
Hom.:
7699
Cov.:
33
AF XY:
0.261
AC XY:
19419
AN XY:
74404
show subpopulations
Gnomad4 AFR
AF:
0.535
Gnomad4 AMR
AF:
0.200
Gnomad4 ASJ
AF:
0.177
Gnomad4 EAS
AF:
0.0559
Gnomad4 SAS
AF:
0.207
Gnomad4 FIN
AF:
0.125
Gnomad4 NFE
AF:
0.170
Gnomad4 OTH
AF:
0.244
Alfa
AF:
0.208
Hom.:
2255
Bravo
AF:
0.284
Asia WGS
AF:
0.161
AC:
558
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
3.6
DANN
Benign
0.53

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs5992493; hg19: chr22-19881556; API